Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen Hurst Insider Profile
11 Followers
Stephen Hurst, Co-Chief Executive Officer at Mind Medicine, holds 41.72M shares in Mind Medicine (Ticker: MNMD). Most recently, Stephen Hurst Sold $1,094,998 shares of Mind Medicine on Jan 04, 2022 for an estimated value of 1.54M.
Stephen Hurst Mind Medicine (MNMD)Co-Chief Executive Officer
Mind Medicine (MNMD)
Co-Chief Executive Officer
Ranked #5,515 out of 98,496 Corporate Insiders
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+83.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Co-Chief Executive Officer
Roles that Stephen Hurst holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stephen Hurst
Stephen Hurst's Trading History
List of latest transactions for each holding click on a transaction to see Stephen Hurst's performance on stock
You May Also Like
Stephen Hurst insider profile FAQ
What is the percentage of profitable transactions made by Stephen Hurst?
The percentage of profitable transactions made by Stephen Hurst is 100%.
What is the average return per transaction made by Stephen Hurst?
The average return per transaction made by Stephen Hurst is 83.30%.
What stocks does Stephen Hurst hold?
Stephen Hurst holds: MNMD stocks.
What was Stephen Hurst’s latest transaction?
Stephen Hurst latest transaction was an Informative Sell of $1.54M.
What was Stephen Hurst's most profitable transaction?
Stephen Hurst’s most profitable transaction was an Informative Sell of MNMD stock on October 13, 2021. The return on the trade was 91.70%.
What is Stephen Hurst's role in Mind Medicine?
Stephen Hurst's role in Mind Medicine is Co-Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.